Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-ovarian cancer migration and toxicity characteristics of a platinum(IV) pro-drug with axial HDAC inhibitor ligands in zebrafish models

Investigational New Drugs(2024)10.1007/s10637-024-01479-3Source: DataRank Database

Anti-ovarian cancer migration and toxicity characteristics of a platinum(IV) pro-drug with axial HDAC inhibitor ligands in zebrafish models is a research paper published in Investigational New Drugs (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.32)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Scheldon D. Irvin,Carol K. Cox,Zhouyang Huang ORCID,Justin J. Wilson ORCID,Jerry D. Monroe

Live enrichment

PubMed:39433643 PMC:PMC11625067 OpenAlex:https://openalex.org/W4403597646

National Science Foundation

Grant: CHE-153163

Cornell University

Grant: College of Arts and Sciences

University of Mississippi Medical Center

Grant: Cancer Center and Research Institute Pilot Grant

National Institutes of Health

Grant: P20 GM104357

NIGMS NIH HHS

Grant: P20 GM121334

National Institutes of Health

Grant: 5P20GM121334-02

Mississippi Center of Excellence in Perinatal Research

National Institutes of Health

Grant: 4P20GM104357-04

Cadiorenal and Metabolic Diseases Research Center

FWCI

0.32

Citation Percentile

0.6%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s10637-024-01479-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s10637-024-01479-3.pdf

publisherhttps://link.springer.com/article/10.1007/s10637-024-01479-3/fulltext.html

journalhttps://doi.org/10.1007/s10637-024-01479-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39433643

Fields of Study

Histone Deacetylase Inhibitors ResearchChemotherapy-induced organ toxicity mitigationReproductive System and Pregnancy

MeSH Terms

AnimalsAntineoplastic AgentsCell MovementCisplatinFemaleHumansLigandsOvarian NeoplasmsPlatinumProdrugsZebrafishCell Line, TumorHistone Deacetylase Inhibitors

Keywords

CisplatinOvarian cancerCancer researchCancer cellCancerPharmacologyHistone deacetylaseChemistryDNA damageZebrafishProgrammed cell deathBiologyApoptosisBiochemistryChemotherapyHistoneDNAGeneticsToxicityPlatinum(iv)Hdac InhibitorXenograftsCisplatin EfficacyOvarian NeoplasmsResearchAntineoplastic AgentsLigandsHistone Deacetylase InhibitorsCell MovementCell Line, TumorAnimalsHumansFemaleProdrugsPlatinum

Sustainable Development Goals

SDG 0: Good health and well-being